From: Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)
Vaccine doses | Total | 0 | 1 | 2 | 3 |
---|---|---|---|---|---|
Adolescents with AIIRD | 1,639 | 451 (27.5%) | 179 (10.9%) | 745 (45.5%) | 264 (16.1%) |
COVID-19 infection | 277 | 234 | 22 | 20 | 1 |
Infections / vaccinated* | 16.9% | 51.9% | 12.3% | 2.7% | 0.4% |
Vaccine effectiveness** | Â | Â | 76.3% | 94.8% | 99.2% |